Clinical Trial Update: Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD [Phase 1]

View source ↗

Summary

Phase 1 PK/PD study of LAS190792 in asthma and COPD completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• LAS190792

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD), Asthma | Phase 1 | Status: COMPLETED | Results posted: 2019-06-21